Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults.

ABSTRACT:

Background

The 2018 cholesterol guidelines of the American Heart Association and the American College of Cardiology (AHA/ACC) changed 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitor (statin) eligibility criteria for primary prevention to include multiple risk enhancers and novel intensive lipid-lowering therapies for secondary prevention.

Objectives

This study sought to determine how guideline changes affected identification for preventive therapy in young adults with premature myocardial infarction (MI).

Methods

The study identified adults presenting with first MI at Duke University Medical Center in Durham, North Carolina. Statin therapy eligibility was determined using the 2013 ACC/AHA and 2018 AHA/ACC guidelines criteria. The study also determined poten

SUBMITTER: Zeitouni M 

PROVIDER: S-EPMC7444655 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature